AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Operating income

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndOperating income (Million JPY)YoY (%)
Mar 31, 202323,018+114.26%
Mar 31, 202210,743-46.19%
Mar 31, 202119,965-6.97%
Mar 31, 202021,460-31.24%
Mar 31, 201931,211-15.59%
Mar 31, 201836,977+15.68%
Mar 31, 201731,966+10.69%
Mar 31, 201628,878-9.68%
Mar 31, 201531,974-23.29%
Mar 31, 201441,683+17.96%
Mar 31, 201335,337

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)